Microbiome-targeted Therapy

Microbiome-Targeted Therapy is a therapeutic strategy that modulates the composition or function of the gastrointestinal microbiota to prevent or treat diarrheal diseases through the selective alteration of microbial communities.

333

Publications

26K

Citations

2.5K

Authors

890

Institutions

Publications per year

2017–2026

287

Authors

2.5K

  1. TJ
    Thomas J. Borody

    Centre For Digestive Diseases, Australia

    7 publications · 1.8K citations

    7

    h-index

  2. BH
    Benjamin H. Mullish

    Imperial College London, United Kingdom

    6 publications · 676 citations

    6

    h-index

  3. ZK
    Zain Kassam

    OpenBiome, United States

    6 publications · 497 citations

    6

    h-index

  4. GI
    Gianluca Ianiro

    Università Cattolica del Sacro Cuore, Italy

    5 publications · 233 citations

    5

    h-index

  5. FZ
    Faming Zhang

    Second Affiliated Hospital of Nanjing Medical University, China

    5 publications · 394 citations

    5

    h-index

1–5 of 2.5K

Venues

  1. Gastroenterology

    17 publications · 1.3K citations

    14

    h-index

  2. Gut Microbes

    9 publications · 704 citations

    9

    h-index

  3. Nature

    7 publications · 497 citations

    7

    h-index

  4. PubMed

    Repository · 5 publications · 184 citations

    5

    h-index

  5. Nature Communications

    5 publications · 327 citations

    5

    h-index

1–5